NVDA vs QLYS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.
Qualys exhibits a dichotomy between strong fundamental health and severe market pessimism. The Piotroski F-Score of 4/9 indicates a stable financial condition, supported by an exceptionally low Debt/Equity ratio (0.09) and high gross margins (82.85%). While the stock is trading significantly below its growth-based intrinsic value ($160.48) and carries an attractive forward P/E of 10.42, this is offset by a bearish technical trend (0/100) and consistent insider selling. The company is a high-quality operator currently trapped in a valuation reset.
Compare Another Pair
Related Comparisons
NVDA vs QLYS: Head-to-Head Comparison
This page compares NVIDIA Corporation (NVDA) and Qualys, Inc. (QLYS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.